Oaktree Acquisition Corp. III Life Sciences | SPAC Research

Oaktree Acquisition Corp. III Life Sciences

Status: Pre-Deal

U=S+W/5 W=S@11.50

IPO Proceeds, $M	$191.99M
IPO Date	Oct 24, 2024
CEO	Zaid Pardesi
Left Lead	Jefferies
IPO Cash in Trust	100.0%
SPAC Tenor	24 months
IPO Sector	Healthcare ▶
IPO Geography	Global
Target Company	TBD
Deal Announced	TBD
Deal Size, $M	TBD
Deal Sector	TBD
Deal Geography	TBD
SEC Filings	www.sec.gov
Approval Vote	TBD
Amendment Vote	TBD

OACC OACCU OACCW

Price	$10.40
Last closing price	$10.40
H/L, today	$10.40 / $10.45
Volume, today	21,941
Volume, 3-month avg.	N/A

Price	$10.45
Last closing price	$10.44
High/low price, today	$10.45 / $10.45
Volume, today	293
Volume, 3-month avg.	N/A

Price	$0.65
Last closing price	$0.65
High/low price, today	$0.65 / $0.72
Volume, today	22
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.